Traders work on the floor of the New York Stock Exchange.

Check out which companies are making headlines before the bell:

MedivationPfizer announced a $14 billion deal to acquire the biotech firm in an all-cash transaction. The deal is worth $81.50 per share and Pfizer expects it to add 5 cents per share to earnings in the first year.